Nippon Shikizai, Inc. (JP:4920)
:4920
Top Page
Nippon Shikizai, Inc.
(4920)
Select Model
Select Model
Rating:68Neutral
Price Target:
¥1,284.00
▲(20.56% Upside)
Action:ReiteratedDate:09/04/25
The overall stock score of 68 reflects strong technical momentum and a reasonable valuation, despite financial performance challenges. The company's revenue growth is a positive indicator, but profitability and cash flow issues need addressing. The absence of significant earnings call data or corporate events means these factors did not influence the score.
Positive Factors
Diversified end markets
Serving cosmetics, pharmaceuticals and industrial applications gives durable revenue diversification across less-correlated end markets. This reduces dependence on any single cycle, supports cross-selling of specialty ingredients, and preserves long-term demand from structural beauty and healthcare trends.
Negative Factors
High leverage
A debt-to-equity ratio of 2.56 and low equity ratio signal material leverage, constraining financial flexibility. High indebtedness raises refinancing and interest-rate sensitivity, limiting the company’s ability to fund strategic investments or absorb demand shocks without additional capital or aggressive cash conversion.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified end markets
Serving cosmetics, pharmaceuticals and industrial applications gives durable revenue diversification across less-correlated end markets. This reduces dependence on any single cycle, supports cross-selling of specialty ingredients, and preserves long-term demand from structural beauty and healthcare trends.
Read all positive factors
Nippon Shikizai, Inc. (4920) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥2.29B
Dividend Yield1.72%
Average Volume (3M)1.10K
Price to Earnings (P/E)3.4
Beta (1Y)0.86
Revenue Growth-6.06%
EPS Growth-97.12%
CountryJP
Employees477
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)80.85
Shares Outstanding2,099,376
10 Day Avg. Volume1,420
30 Day Avg. Volume1,096
Financial Highlights & Ratios
PEG Ratio-0.25
Price to Book (P/B)0.64
Price to Sales (P/S)0.14
P/FCF Ratio-4.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nippon Shikizai, Inc. Business Overview & Revenue Model
Company Description
Nippon Shikizai, Inc. researches and develops, manufactures, and sells cosmetics in Japan and internationally. The company offers lip products, such as lipsticks, and lip liners and glosses; eye products, including eye shadows, mascaras, eye liner...
How the Company Makes Money
Nippon Shikizai generates revenue through the production and sale of its specialty chemicals and functional materials. The company has established multiple revenue streams, including direct sales to manufacturers in the cosmetics and pharmaceutica...
Nippon Shikizai, Inc. Financial Statement Overview
Summary
Income Statement
70
Positive
Balance Sheet
60
Neutral
Cash Flow
55
Neutral
| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.68B | 17.63B | 15.05B | 11.76B | 8.70B | 9.14B |
| Gross Profit | 2.28B | 3.02B | 2.75B | 2.03B | 1.41B | 1.05B |
| EBITDA | 1.22B | 1.40B | 1.32B | 975.73M | 517.34M | -19.00M |
| Net Income | 120.55M | 216.30M | 398.11M | 246.29M | -122.03M | -848.67M |
Balance Sheet | ||||||
| Total Assets | 17.01B | 16.95B | 17.16B | 16.05B | 15.35B | 15.55B |
| Cash, Cash Equivalents and Short-Term Investments | 873.70M | 949.02M | 1.39B | 1.33B | 1.32B | 1.08B |
| Total Debt | 9.28B | 9.73B | 9.51B | 10.04B | 10.22B | 10.53B |
| Total Liabilities | 13.26B | 13.15B | 13.63B | 13.04B | 12.40B | 12.46B |
| Stockholders Equity | 3.75B | 3.80B | 3.53B | 3.01B | 2.95B | 3.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -572.15M | 591.79M | 341.59M | 541.45M | -1.50B |
| Operating Cash Flow | 0.00 | 567.79M | 1.25B | 615.40M | 781.34M | 405.52M |
| Investing Cash Flow | 0.00 | -1.11B | -438.36M | -252.81M | -187.87M | -2.08B |
| Financing Cash Flow | 0.00 | 95.46M | -697.50M | -413.11M | -338.23M | 1.87B |
Nippon Shikizai, Inc. Technical Analysis
Positive
1065.00
Price Trends
1120.42
Negative
1117.31
Negative
1081.29
Positive
Market Momentum
-6.34
Negative
53.43
Neutral
70.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4920, the sentiment is Positive. The current price of 1065 is above the 20-day moving average (MA) of 1055.40, below the 50-day MA of 1120.42, and below the 200-day MA of 1081.29, indicating a neutral trend. The MACD of -6.34 indicates Negative momentum. The RSI at 53.43 is Neutral, neither overbought nor oversold. The STOCH value of 70.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4920.
Nippon Shikizai, Inc. Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥153.87B | 29.58 | ― | 5.00% | 1.41% | 0.75% | |
71 Outperform | ¥88.09B | 22.92 | 7.23% | 3.53% | 3.05% | -32.61% | |
69 Neutral | ¥6.54B | 12.52 | ― | 2.38% | -0.79% | ― | |
68 Neutral | ¥2.29B | 3.43 | ― | 1.72% | -6.06% | -97.12% | |
66 Neutral | ¥34.35B | 6.92 | ― | 1.81% | 0.22% | 4.15% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | ¥5.40B | -33.12 | ― | 1.68% | 8.46% | ― |
* Consumer Defensive Sector Average
JP:4920
Nippon Shikizai, Inc.
1,063.00
113.08
11.90%
JP:4919
Milbon Co
2,761.00
97.49
3.66%
JP:4923
Cota Co., Ltd.
1,167.00
-133.82
-10.29%
JP:4925
HABA Laboratories, Inc.
1,723.00
99.89
6.15%
JP:4926
C'BON COSMETICS Co., Ltd.
1,260.00
167.33
15.31%
JP:4928
Noevir Holdings Co., Ltd.
4,450.00
596.81
15.49%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.